{"id":14262,"date":"2021-03-26T15:22:08","date_gmt":"2021-03-26T14:22:08","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?p=14262"},"modified":"2021-03-26T15:22:08","modified_gmt":"2021-03-26T14:22:08","slug":"la-fda-approuve-lidecabtagene-vicleucel-de-bristol-myers-squibb-et-bluebird-bio-la-premiere-therapie-cellulaire-anti-bcma-car-t-pour-le-myelome-multiple-recidivant-ou-refractaire","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/la-fda-approuve-lidecabtagene-vicleucel-de-bristol-myers-squibb-et-bluebird-bio-la-premiere-therapie-cellulaire-anti-bcma-car-t-pour-le-myelome-multiple-recidivant-ou-refractaire\/","title":{"rendered":"La FDA approuve l’idecabtagene vicleucel de Bristol Myers Squibb et bluebird bio, la premi\u00e8re th\u00e9rapie cellulaire anti-BCMA CAR T pour le my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[21],"tags":[],"ppma_author":[442],"class_list":["post-14262","post","type-post","status-publish","format-standard","hentry","category-communique-de-presse","author-marion"],"aioseo_notices":[],"authors":[{"term_id":442,"user_id":2,"is_guest":0,"slug":"marion","display_name":"HematoStat.net (M)","avatar_url":{"url":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2024\/01\/favicon-hematoStat.png","url2x":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2024\/01\/favicon-hematoStat.png"},"first_name":"HematoStat.net (M)","last_name":"","user_url":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/14262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=14262"}],"version-history":[{"count":0,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/14262\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=14262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=14262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=14262"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=14262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}